January 20, 2017
Accriva Diagnostics Acquired by Werfen and Instrumentation Laboratory
The Accriva organization would like to announce that we have been acquired by Werfen Life Group, S.A., (Werfen), and its subsidiary, Instrumentation Laboratory (IL). Accriva’s globally recognized portfolio of POC diagnostic products for coagulation and anti-platelet therapy response will allow IL to establish a market-leading position in hospital-based POC Hemostasis testing, expand its position in POC Critical Care testing and complement its leadership of the Hemostasis Laboratory market.
We are committed to assuring that all of our customers and partners will experience no disruptions as a result of this change.
View the press release below or view it online.